These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8110683)

  • 1. Therapeutic ptosis with botulinum toxin in epikeratoplasty.
    Freegard T; Mackie I; Rostron C
    Br J Ophthalmol; 1993 Dec; 77(12):820-2. PubMed ID: 8110683
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporary tarsorrhaphy induced with type A botulinum toxin.
    Wuebbolt GE; Drummond G
    Can J Ophthalmol; 1991 Dec; 26(7):383-5. PubMed ID: 1764645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to ramamurthi and rahman: induction of ptosis with botulinum toxin for thr treatment of recurrent corneal erosions.
    Bailey CS
    Eye (Lond); 2007 Aug; 21(8):1128. PubMed ID: 17571089
    [No Abstract]   [Full Text] [Related]  

  • 6. Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis.
    Halkiadakis I; Iliaki O; Kalyvianaki MI; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(1):55-7. PubMed ID: 17366121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A induced protective ptosis.
    Adams GG; Kirkness CM; Lee JP
    Eye (Lond); 1987; 1 ( Pt 5)():603-8. PubMed ID: 3446541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin injection for production of ptosis].
    Merté RL; Lanzl IM
    Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic use of botulinum toxin in patients with Duane syndrome.
    Dawson EL; Maino A; Lee JP
    Strabismus; 2010 Mar; 18(1):21-3. PubMed ID: 20230203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].
    Dintelmann T; Sold J; Grehn F
    Ophthalmologe; 2005 Mar; 102(3):247-50. PubMed ID: 15322802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].
    Schilimow A; Wiechens B
    Ophthalmologe; 2017 Aug; 114(8):745-747. PubMed ID: 27766386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cornea protection in ptosis induced by botulinum injection].
    Brans JW; Aramideh M; Schlingemann RO; Oen VM; Speelman JD; Ongerboer de Visser BW
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1031-3. PubMed ID: 8684496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraclonidine in the treatment of ptosis.
    Wijemanne S; Vijayakumar D; Jankovic J
    J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing success and dose-effect relation of botulinum A treatment.
    Abbasoglu OE; Sener EC; Sanac AS
    Eye (Lond); 1996; 10 ( Pt 3)():385-91. PubMed ID: 8796167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasms and eyelid apraxia.
    Verhulst S; Smet H; De Wilde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1994; 252():51-3. PubMed ID: 7894756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral ptosis: a rare presentation.
    Farooq S; Dukht U; Jaffar S
    J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.